Total Funding
57
48
Total FundingSeries B raised
Growth Score
-5 pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
63064
iVeena develops ocular drug products that eliminate the need for eye drop application and painful injections.
- Gerald Simmons: CEO & Board Director
Bala Ambati: President, Founder, Board Director
About the Company
iVeena has five products in the late pre-clinical and research phases. Targeted indications include post-surgery cataract inflammation, macular degeneration (Wet AMD), diabetic retinopathy, and glaucoma.
iVeena Delivery Systems, Inc. was founded in 2006 by Bala Ambati and is based in Salt Lake City, Utah.
